Abstracts tagged "Chronic pain"

Abstract Number: 2721 • 2019 ACR/ARP Annual Meeting
Subjective and Objective Dyscognition in Adolescents with Juvenile Fibromyalgia Syndrome
Sabrina Gmuca¹, Maitry Sonagra ², Rui Xiao ², Elizabeth Mendoza ², Kimberly S. Miller ³, Nina H. Thomas ¹, Pamela F. Weiss ¹, David D. Sherry ¹ and Jeffrey Gerber ², ¹Children's Hospital of Philadelphia, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, ³Children's Hospital fo Philadelphia, Philadelphia, PA
Background/Purpose: Dyscognition, including loss of mental clarity and problems with attention and memory, often affects adolescents with juvenile fibromyalgia syndrome (JFMS). Our understanding of this…
Abstract Number: 2760 • 2019 ACR/ARP Annual Meeting
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
Michael Billard ¹, John Todhunter ¹, Margaret Fleming ¹, Tim Warneke¹, Yuhui Qiu ², Nhu Ly ², William Aronstein ² and William Moore ¹, ¹Vizuri Health Sciences, LLC, Columbia, MD, ²CTI Clinical Trial & Consulting, Covington, KY
Background/Purpose: There is considerable unmet medical need for an osteoarthritic knee pain (OAKP) treatment that does not require regular daily use, does not carry gastrointestinal…
Abstract Number: 2766 • 2019 ACR/ARP Annual Meeting
Patient Preferences for Attributes of Treatments for Chronic Pain Associated with Osteoarthritis Pain and Chronic Low Back Pain That Differentiate Nerve-Growth Factor Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Opioids in the United States: A Discrete-Choice Experiment
Dennis Turk ¹, Marco Boeri², Lucy Abraham ³, Brett Hauber ⁴, Joanna Atkinson ³, Andrew Bushmakin ⁵, Joseph Cappelleri ⁵, Leo Russo ⁶, Lars Viktrup ⁷ and David Walsh ⁸, ¹University of Washington, Seattle, ²RTI Health Solutions, Belfast, Northern Ireland, United Kingdom, ³Pfizer, LTD, Surrey, England, United Kingdom, ⁴RTI Health Solutions, Research Triangle Park, NC, ⁵Pfizer Inc, Groton, CT, ⁶Pfizer, Inc., Collegeville, PA, ⁷Eli Lilly and Company, Indianapolis, IN, ⁸Sherwood Forest Hospitals NHS Foundation Trust, Nottingham, United Kingdom
Background/Purpose: Monoclonal antibodies that inhibit nerve growth factor (NGF-abs) may offer an alternative to current nonsteroidal anti-inflammatory drug (NSAID) and opioid treatments for osteoarthritis (OA)…
Abstract Number: 2929 • 2019 ACR/ARP Annual Meeting
Cannabis Use Among Patients in a Large US Rheumatic Disease Registry
Kristin Wipfler ¹, Teresa Simon², Patricia Katz ³, Frederick Wolfe ⁴ and Kaleb Michaud ⁵, ¹FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, ²Bristol-Myers Squibb*, Princeton, NJ, ³University of California, San Francisco, san francisco, CA, ⁴FORWARD, The National Databank for Rheumatic Diseases & University of Nebraska Medical Center, Wichita, KS, ⁵FORWARD, The National Databank for Rheumatic Diseases and University of Nebraska Medical Center, Wichita, KS
Background/Purpose: Legalization of cannabis use is rapidly increasing worldwide, raising the need to evaluate trends and medical implications. A systematic literature review showed inconsistent results…
Abstract Number: 222 • 2019 ACR/ARP Annual Meeting
Acupuncture for Chronic Musculoskeletal Pain: A Review of Randomized Controlled Trials
Yujuan Zhang¹ and Chenchen Wang ², ¹Floating Hospital at Tufts Medical Center, Boston, ²Tufts Medical Center, Boston
Background/Purpose: Acupuncture has been widely used for pain relief in adults. Evidence on effects of acupuncture for pediatric chronic musculoskeletal pain is scarce. We have reviewed existing…
Abstract Number: 256 • 2019 ACR/ARP Annual Meeting
Chronic Musculoskeletal Pain and Its Initial Management in Children, Adolescents and Young Adults in the United States
Debbie Ehrmann Feldman¹ and Richard Nahin ², ¹University of Montreal, Montreal, QC, Canada, ²National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, MD
Background/Purpose: Chronic musculoskeletal pain can affect up to 20% of persons under the age of 25 and is a risk factor for persistent chronic musculoskeletal…
Abstract Number: 274 • 2019 ACR/ARP Annual Meeting
Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis
Dina Jones¹, Louise Murphy ², Ranjita Misra ¹, Alison Vargovich ³, Dana Guglielmo ⁴, Maura Robinson ¹, Samantha Shawley-Brzoska ¹, Sijin Wen ¹, Megan Burkart ¹ and Richard Vaglienti ¹, ¹West Virginia University, Morgantown, WV, ²Centers for Disease Control and Prevention, Division of Population Health, Atlanta, ³University at Buffalo - SUNY, Buffalo, NY, ⁴Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA
Background/Purpose: In 2016, 1 in 5 US adults reported chronic pain (CP). Osteoarthritis and rheumatoid arthritis are top causes of CP. The Stanford University Chronic…
Abstract Number: 831 • 2019 ACR/ARP Annual Meeting
Maintaining Musculoskeletal Health: A Randomized Controlled Prevention Trial Amongst People at High Risk of Developing Chronic Widespread Pain
Gary Macfarlane¹, Marcus Beasley ¹, Neil Scott ¹, Gordon Prescott ², Paul McNamee ¹, John McBeth ³, Gareth Jones ¹, Neil Basu ⁴, Phil Hannaford ¹, Phil Keeley ⁵ and Karina Lovell ⁶, ¹University of Aberdeen, Aberdeen, United Kingdom, ²University of Central Lancashire, Preston, United Kingdom, ³Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, ⁴University of Glasgow, Glasgow, United Kingdom, ⁵University of Huddersfield, Huddersfield, United Kingdom, ⁶University of Manchester, Manchester, United Kingdom
Background/Purpose: Cognitive behaviour therapy (CBT) is effective in the management of fibromyalgia (and its characteristic feature Chronic Widespread Pain (CWP). CBT is recommended in all…
Abstract Number: 1754 • 2019 ACR/ARP Annual Meeting
Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain
Matthew Taylor ¹, Sabrina Gmuca ², Lakshmi Moorthy ³, Alexis Boneparth ⁴ and Daniel Horton³, ¹Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, ²Children's Hospital of Philadelphia, Philadelphia, PA, ³Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, ⁴Columbia University Medical Center, New York, NY
Background/Purpose: Chronic musculoskeletal (MSK) pain has been associated with chronic illnesses, including mental disorders, and with high rates of pain medication use, often in referral…
Abstract Number: 2076 • 2019 ACR/ARP Annual Meeting
The Opioid Epidemic: The Rheumatology Response to Management of Chronic Pain
Michael Grant¹, Alysia Kwiatkowski ¹ and Najia Shakoor ¹, ¹Rush University Medical Center, Chicago, IL
Background/Purpose: Pain is the hallmark symptom of many rheumatologic conditions and chronic pain management is a major part of clinical practice in rheumatology. Therefore, as…
Abstract Number: 1177 • 2018 ACR/ARHP Annual Meeting
How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the U.S.?
Debbie Ehrmann Feldman¹, Lisa Carlesso² and Richard Nahin³, ¹Université de Montréal, Montréal, QC, Canada, ²School of Rehabilitation, Université de Montréal, Montreal, QC, Canada, ³NIH, Bethesda, MD
Background/Purpose: Chronic musculoskeletal pain (e.g. back and neck pain, pain due to arthritis, leg pain, arm pain) affects up to 24% of the general population.…
Abstract Number: 1433 • 2018 ACR/ARHP Annual Meeting
The Role of Patient and Parental Resilience in Amplified Musculoskeletal Pain Syndrome
Sabrina Gmuca¹, Audrey Urquhart¹, Pamela F. Weiss², Jeffrey S. Gerber³ and David D. Sherry¹, ¹Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²Division of Rheumatology, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ³Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose: Resilience is a dynamic process of positive adaptation in the context of significant adversity. While higher levels of resilience have been associated with improved…
Abstract Number: 1946 • 2018 ACR/ARHP Annual Meeting
Changing the Conversation about Pain: Development and Testing of an Interprofessional Pain CME Applicable for Rheumatologists and Rheumatology Health Professionals
Kim Jones¹, Catriona Buist², Denise Taray³, Rubin Halperin⁴, Mark Stephens³ and Nora Stern⁴, ¹Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, ²Anesthesiology and Pain Management, Oregon Health & Science University, Portland, OR, ³Oregon State Pain Management Commission, Portland, OR, ⁴Providence St Joseph Health and Services, Portland, OR
Background/Purpose: Pain is a near universal symptom of rheumatic diseases. Persistent pain can cause changes in the central and peripheral nervous system transforming pain from…
Abstract Number: 2345 • 2018 ACR/ARHP Annual Meeting
Systematic Review of Patient Decision Aids for Chronic Musculoskeletal Pain
Rabih Nayfe¹, Emily Bowen², Nathaniel Milburn², Helen Mayo², Ethan Halm², MC. Reid³, Liana Fraenkel⁴ and Una E. Makris⁵, ¹Department of Medicine, UT Southwestern Medical Center, Dallas, TX, ²UT Southwestern Medical Center, Dallas, TX, ³Weill Cornell Medicine, New York, NY, ⁴Yale University School of Medicine, New Haven, CT, ⁵UT Southwestern Medical Center and Dallas VA, Dallas, TX
Background/Purpose: Chronic musculoskeletal (MSK) pain is common and disabling; it is among the top reasons for doctor’s visits in the US. Most treatment decisions for…
Abstract Number: 2873 • 2018 ACR/ARHP Annual Meeting
Remaining Pain and Widespread, Non-Inflammatory Pain Distribution during the First 12 Months after RA Diagnosis
Yvonne C. Lee¹, Orit Schieir², Marie-France Valois³, Susan J. Bartlett⁴, Gilles Boire⁵, Boulos Haraoui⁶, Carol A Hitchon⁷, Edward C. Keystone⁸, Diane Tin⁹, Carter Thorne¹⁰, Janet E. Pope¹¹ and Vivian P. Bykerk¹², ¹Northwestern University Feinberg School of Medicine, Chicago, IL, ²McGill University, Montreal, ON, Canada, ³McGill University, Montreal, QC, Canada, ⁴Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Rheumatology Division, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, ⁶Institut de Recherche en Rhumatologie de Montréal (IRRM), Montreal, QC, Canada, ⁷University of Manitoba, Winnipeg, MB, Canada, ⁸Mount Sinai Hospital, Toronto, ON, Canada, ⁹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹⁰University of Toronto, Newmarket, ON, Canada, ¹¹Department of Medicine, University of Western Ontario, London, ON, Canada, ¹²Hospital for Special Surgery, New York, NY
Background/Purpose: The incidence of fibromyalgia is highest in the first 12 months after RA diagnosis,1 indicating that this period may represent a critical window during…